Skip to main content
Equibles
MPLT logo

MPLT · MapLight Therapeutics, Inc.

Track MPLT — free

Use MPLT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MPLT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$13.00 -0.79 (-5.69%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$602.91M
Shares
46.38M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$13.00 Open$13.88 Day$12.80–14.14 Available close range$9.91–39.80 Avg vol 30d624K Short int3.4M · 7.4% float · 5.7d Short vol38% Last earningsJul 27, 2026 DataOct 2025–Sep 2026 Filing10-Q · Aug 13

The closing range uses available history since Oct 27, 2025; less than a full year is stored.

Up next

Latest filing: 10-Q
filed Aug 13, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$229.83M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
0.3
Trailing earnings · reciprocal yield 342.5%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$304.73M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+5,854.0%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
7.4%
Latest settlement · 5.7 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.60
Technical
price trend
Sell
50 / 200-day cross Death cross
Price vs 200-day avg −41%
below
Price vs 50-day avg −36%
below
RSI (14) 40
neutral
MACD trend Positive
52-week position 10%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +12%
trailing
6-month return −26%
trailing
YTD return −26%
this year
Relative strength −44%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) Death cross
50d $20 › 200d $22 — 200d above 50d
Institutional flow Accumulating
+31% holders QoQ · +37 funds added
Insider flow Accumulating
Net +$58.8M over 90 days · 60% sells
Short interest Rising
7.39% of float · ▲ +5.9% MoM · 5.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
106 holders — 13F breadth
Squeeze score 56
elevated · 0–100
Fundamentals
Fair
EPS growth +82%
Y/Y
Free cash flow $-138.6M
Quant / Vol
risk profile
Very High
Volatility 119%
annualized · 1-yr
Max drawdown −75%
past year
ATR 10.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
4 · 2 · 1
50 / 200-day cross
Death cross Bearish
Price vs 200-day avg
−41% Bearish
Price vs 50-day avg
−36% Bearish
RSI (14)
40 Neutral
MACD trend
Positive Bullish
52-week position
10% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) Death cross
50d $20 › 200d $22 — 200d above 50d
Institutional flow Accumulating
+31% holders QoQ · +37 funds added
Insider flow Accumulating
Net +$58.8M over 90 days · 60% sells
Short interest Rising
7.39% of float · ▲ +5.9% MoM · 5.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
106 holders — 13F breadth
Price context
position in its available closing range
Range low $10 Now $13 · 10% Range high $40
vs 200-day avg -41% vs 50-day avg -36% 50-day below 200-day death cross

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MPLT
MapLight Therapeutics, Inc.
this stock
$602.91M -26.0% — — 7.4%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.40B +13.7% +46.2% 30.0 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $80.46B +1.2% +20.8% 19.4 2.5%
ARGX
Argenx SE
 $61.60B +17.1% — — 2.0%
MRNA
Moderna, Inc.
 $57.48B +388.2% +4.3% — 9.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
106
% held
56.7%
Net QoQ
+1.6M sh
Top holder
NOVO HOLDINGS A/S
Held Float
View
Held by Funds
Fund positions
133
View
Short & Settlement
Short Interest Rising
Shares short
3.4M
Days to cover
5.7d
Change
+190.6K sh
View
Short Volume
Short vol %
38%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
699
Value
$8.1K
As of
Aug 14, 2026
View
Off-Exchange
Off-exchange %
45.6%
Week of
Aug 3, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$58.8M
Buyers / Sellers
2 / 3
Buyers Sellers
View
Financials
Financials
Net income (FY)
$-161.2M
EPS diluted
$-18.56
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 13, 2026
This year
13
View
Proposed Sales
Value
$287.5K
Shares
22.1K
Filed
Aug 3, 2026
View
Exempt Offerings
Offering
$372.4M
Filed
Jul 28, 2025
View
Earnings & Events
Earnings Calls
Last call
Jul 27, 2026
View

Performance

5D 20D 120D MTD YTD
MPLT -1.1% +12.3% -26.0% +0.2% -26.0%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY +0.1% +14.0% -43.8% +0.6% -38.1%
Key facts CIK 1770069 CUSIP 56565P103 13F (30d) 67 filings 67 filers Visit website Investor relations